Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 165
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05255991 | Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | ||
| NCT04868292 | Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers | ||
| NCT03497689 | EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension | ||
| NCT03055221 | TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) | ||
| NCT02276872 | Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years | ||
| NCT03047369 | The Myelin Disorders Biorepository Project | ||
| NCT01353027 | Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus | ||
| NCT01007890 | Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer | ||
| NCT00373360 | Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin | ||
| NCT05421897 | Rapid Administration Pilot for Infusing Dinutuximab | ||
| NCT00651885 | Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure | ||
| NCT01043627 | Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) | ||
| NCT02847260 | Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) | ||
| NCT06477640 | Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension | ||
| NCT01560637 | An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension | ||
| NCT00848939 | Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis | ||
| NCT05101564 | Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer | ||
| NCT05735249 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects | ||
| NCT05231122 | Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer | ||
| NCT03804944 | Converting HR+ Breast Cancer Into an Individualized Vaccine | ||
| NCT06580444 | Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study | ||
| NCT00848107 | Open-Label Study of Oral Treprostinil in Digital Ulcers | ||
| NCT02603068 | Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis | ||
| NCT00067041 | Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft | ||
| NCT03332667 | MIBG With Dinutuximab +/- Vorinostat | ||
| NCT01302444 | Treprostinil Combined With Tadalafil for Pulmonary Hypertension | ||
| NCT04712266 | A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes | ||
| NCT00147199 | Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) | ||
| NCT02360345 | Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly | ||
| NCT02630316 | Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE | ||
| NCT02882126 | An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension | ||
| NCT00760916 | FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) | ||
| NCT04478071 | Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) | ||
| NCT04850105 | A Non-interventional Cohort Safety Study of Patients With hATTR-PN | ||
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | ||
| NCT03043651 | Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF | ||
| NCT03180957 | Repurposing Anti-TNF for Treating Dupuytren's Disease | ||
| NCT01027949 | An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension | ||
| NCT01042158 | A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis | ||
| NCT01324999 | Tadalafil for Sarcoidosis Associated Pulmonary Hypertension | ||
| NCT00058929 | A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension | ||
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ||
| NCT03037580 | Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction | ||
| NCT03833323 | Implantable System for Remodulin Post-Approval Study | ||
| NCT04084678 | A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH | ||
| NCT01260454 | The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain | ||
| NCT05564637 | A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension | ||
| NCT03012646 | Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD | ||
| NCT02663895 | Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis | ||
| NCT06388421 | DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) |
